Problem statement: Answer the MCQ question.
Question: Which compound exhibits a -18.646% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) Cc1cc(C)cc(NC(=O)c2nnn(Cc3cc(C)ccc3C)c2N)c1
b) Cn1c(SCC(=O)Nc2ccc3c(c2)CCC3)nnc1C1CC1
c) COC(=O)C1=C(CS(=O)(=O)c2ccccc2)NC(=O)NC1c1ccc(OC)c(OC)c1
Answer: b. Cn1c(SCC(=O)Nc2ccc3c(c2)CCC3)nnc1C1CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1c(SCC(=O)Nc2ccc3c(c2)CCC3)nnc1C1CC1
Cn1c(SCC(=O)Nc2ccc3c(c2)CCC3)nnc1C1CC1
2-[(5-cyclopropyl-4-methyl-1,2,4-triazol-3-yl)sulfanyl]-N-(2,3-dihydro-1H-inden-5-yl)acetamide